Your browser is no longer supported. Please, upgrade your browser.
Settings
DBV Invesco DB G10 Currency Harvest daily Stock Chart
DBV [NYSE]
Invesco DB G10 Currency Harvest
Index- P/E- EPS (ttm)- Insider Own- Shs Outstand- Perf Week-1.59%
Market Cap- Forward P/E- EPS next Y- Insider Trans- Shs Float- Perf Month2.34%
Income- PEG- EPS next Q- Inst Own- Short Float- Perf Quarter1.37%
Sales- P/S- EPS this Y- Inst Trans- Short Ratio0.24 Perf Half Y2.85%
Book/sh- P/B- EPS next Y- ROA- Target Price- Perf Year2.51%
Cash/sh- P/C- EPS next 5Y- ROE- 52W Range21.17 - 25.50 Perf YTD3.72%
Dividend0.02 P/FCF- EPS past 5Y- ROI- 52W High-3.56% Beta-
Dividend %0.08% Quick Ratio- Sales past 5Y- Gross Margin- 52W Low16.17% ATR0.20
Employees- Current Ratio- Sales Q/Q- Oper. Margin- RSI (14)54.91 Volatility0.34% 0.43%
OptionableNo Debt/Eq- EPS Q/Q- Profit Margin- Rel Volume0.34 Prev Close24.69
ShortableYes LT Debt/Eq- Earnings- Payout- Avg Volume3.43K Price24.59
Recom- SMA200.76% SMA501.66% SMA2002.55% Volume1,163 Change-0.40%
Nov-16-18 01:31AM  DBV Technologies Appoints Daniel Tassé as Chief Executive Officer GlobeNewswire
Nov-09-18 01:32AM  DBV Technologies to Present Data Further Supporting the Use of Epicutaneous Immunotherapy for the Treatment of Peanut Allergy at the 2018 ACAAI Meeting GlobeNewswire
Oct-30-18 02:31AM  DBV Technologies Reports September 30, 2018 Cash Position GlobeNewswire
Oct-26-18 01:31AM  DBV Technologies Announces Initiation of Part B of Phase III Study in Peanut-Allergic Toddlers GlobeNewswire
Oct-22-18 01:32AM  DBV Technologies Announces Submission of Biologics License Application for Viaskin Peanut to the U.S. Food and Drug Administration GlobeNewswire
Sep-25-18 01:31AM  DBV Technologies to Present at the Cantor Global Healthcare Conference GlobeNewswire
Sep-12-18 01:31AM  DBV Technologies Announces Positive DSMB Review of Part A of Phase III Study in Peanut-Allergic Toddlers GlobeNewswire
Sep-07-18 01:31AM  DBV Technologies : Reports First Half 2018 Financial Results GlobeNewswire
Sep-05-18 01:31AM  DBV Technologies, Geneva University Hospitals and BioNet-Asia Presented Additional Phase I Data on the Use of an Investigational Epicutaneous Patch in Boosting Pertussis Vaccination at the ECI GlobeNewswire
Aug-31-18 01:31AM  DBV Technologies to Attend Upcoming Investor Conferences GlobeNewswire
Jul-27-18 01:31AM  DBV Technologies Reports June 30, 2018 Cash Position GlobeNewswire
Jul-26-18 01:31AM  DBV Technologies Appoints Industry Leader Kevin Trapp as Chief Commercial Officer GlobeNewswire
Jun-22-18 04:01PM  DBV Technologies Announces Results of its 2018 Ordinary and Extraordinary General Meeting and the Appointment of Joan Schmidt as Executive Vice President, General Counsel GlobeNewswire
Jun-05-18 01:31AM  DBV Technologies to Attend Upcoming Investor Conferences GlobeNewswire
Jun-01-18 01:31AM  DBV Technologies: Ordinary and Extraordinary General Meeting of June 22, 2018 - Procedures for Obtaining Preparatory Documents for the General Meeting GlobeNewswire
May-29-18 01:31AM  DBV Technologies Shows Commitment to the Development of Treatments for Food Allergies at EAACI 2018 GlobeNewswire
May-16-18 01:31AM  DBV Technologies Announces Appointment of Michel de Rosen to its Board of Directors GlobeNewswire
May-14-18 08:32AM  DBV Technologies Partners with FARE to Help Raise Awareness of Food Allergies in Support of the 21st Anniversary of Food Allergy Awareness Week GlobeNewswire
May-08-18 01:31AM  DBV Technologies to Present New Clinical Data from Viaskin Platform at the 2018 EAACI Meeting GlobeNewswire
May-01-18 01:31AM  DBV Technologies to Attend Upcoming Investor Conferences GlobeNewswire
Apr-27-18 01:31AM  DBV Technologies Reports March 31, 2018 Cash Position GlobeNewswire
Apr-03-18 01:31AM  DBV Technologies to Attend the 11th Kempen Life Sciences Conference GlobeNewswire
Mar-26-18 04:02PM  DBV Technologies Announces Closing of Underwriters' Option to Purchase Additional Shares in Global Offering GlobeNewswire
Mar-23-18 04:02PM  DBV Technologies Announces Closing of Global Offering and Full Exercise of Underwriters' Option to Purchase Additional Shares GlobeNewswire
Mar-21-18 03:01AM  DBV Technologies Announces Pricing of $150.0 million (122.5 million) Global Offering of Ordinary Shares, Including in the Form of American Depositary Shares GlobeNewswire
Mar-20-18 04:02PM  DBV Technologies Announces the Launch of a Proposed Global Offering of Ordinary Shares, Which May Be in the Form of American Depositary Shares GlobeNewswire
Mar-16-18 04:31PM  DBV Technologies Announces Filing of 2017 "Document de Référence" and 2017 Annual Report on Form 20-F GlobeNewswire
Mar-14-18 02:31AM  DBV Technologies Reports Full Year 2017 Financial Results GlobeNewswire
Mar-07-18 01:31AM  DBV Technologies to Present at the Barclays Global Healthcare Conference GlobeNewswire
Feb-26-18 05:06PM  DBV Technologies Announces Results from Phase II Study of Viaskin Milk in Milk-Allergic Patients GlobeNewswire
Feb-20-18 01:31AM  DBV Technologies Reports December 31, 2017 Cash Position GlobeNewswire
Feb-14-18 01:31AM  DBV Technologies Provides Update on Regulatory Progress for Viaskin Peanut GlobeNewswire
Feb-12-18 09:01AM  DBV Technologies présente de nouveaux résultats lors du Congrès Annuel 2018 de l'AAAAI/WAO concernant sa plateforme Viaskin GlobeNewswire
Feb-01-18 01:31AM  DBV Technologies to Attend Upcoming Investor Conferences GlobeNewswire
Jan-16-18 01:31AM  Half-Year Report on DBV Technologies Liquidity Contract with Natixis GlobeNewswire
Jan-03-18 01:31AM  DBV Technologies to Present at the 36th Annual J.P. Morgan Healthcare Conference GlobeNewswire
Dec-04-17 01:31AM  DBV Technologies CEO, Chairman, and Co-Founder, Dr. Pierre-Henri Benhamou Recognized for His Lasting Impact on the Food Allergy Community and Research Advancement by FARE (Food Allergy Research & E... GlobeNewswire
Nov-14-17 11:31AM  DBV Technologies Announces Publication of Positive Data from Phase IIb Trial and Long-Term Study of Viaskin Peanut in the Journal of the American Medical Association GlobeNewswire
Oct-31-17 02:32AM  DBV Technologies Reports September 30, 2017 Cash Position GlobeNewswire
Oct-20-17 05:17PM  DBV Technologies Announces Topline Results of Phase III Clinical Trial in Peanut-Allergic Patients Four to 11 Years of Age GlobeNewswire
Oct-12-17 01:32AM  DBV Technologies Announces Completion of Blinded Period in REALISE Study of Viaskin Peanut GlobeNewswire
Sep-01-17 01:32AM  DBV Technologies to Attend Upcoming Investor Conferences GlobeNewswire
Aug-29-17 01:32AM  DBV Technologies Announces Completion of Enrollment in Phase III Extension Study of Viaskin Peanut GlobeNewswire
Aug-02-17 01:32AM  DBV Technologies Initiates Phase III Study of Viaskin Peanut in Peanut-Allergic Patients One to Three Years of Age GlobeNewswire
Jul-31-17 04:51AM  US Dollar Bearishness Is Overdone Barrons.com
Jul-28-17 01:32AM  DBV Technologies Reports First Half 2017 Financial Results GlobeNewswire
Jun-17-17 02:34AM  DBV Technologies Highlights Poster Presentations on EPIT® at the 2017 EAACI Congress GlobeNewswire
Jun-15-17 04:31PM  DBV Technologies Announces Results of its 2017 Ordinary and Extraordinary General Meeting GlobeNewswire
04:31PM  DBV Technologies Announces Appointment of Julie O'Neill to Board of Directors GlobeNewswire
Jun-01-17 01:31AM  DBV Technologies to Attend Upcoming Investor Conferences GlobeNewswire
May-24-17 04:31PM  DBV Technologies : Ordinary and Extraordinary General Meeting of June 15, 2017 Procedures for Obtaining Preparatory Documents for the General Meeting GlobeNewswire
May-22-17 09:33PM  Currencies Quiet After Trumps Good Weekend Harvest Exchange
May-08-17 01:32AM  DBV Technologies Highlights Research Presentation of EPIT® for the Treatment of Crohn's Disease at Digestive Disease Week 2017 GlobeNewswire
May-02-17 01:53AM  DBV Technologies to Attend Upcoming Investor Conferences GlobeNewswire
Apr-28-17 01:49AM  DBV Technologies Reports March 31, 2017 Cash Position GlobeNewswire
Apr-05-17 01:32AM  DBV Technologies to Attend the 10th Kempen Life Sciences Conference GlobeNewswire
01:32AM  DBV Technologies to Attend the 10th Kempen Life Sciences Conference
Mar-30-17 04:31PM  DBV Technologies, BioNet-Asia and Geneva University Hospitals Announce Phase I Trial Results of Viaskin rPT in Pertussis Booster Vaccination GlobeNewswire
Mar-22-17 05:31PM  DBV Technologies : Announces Filing of its 2016 "Document de Référence" and Annual Report on Form 20-F GlobeNewswire
Mar-15-17 02:31AM  DBV Technologies Reports Full Year 2016 Financial Results GlobeNewswire
Mar-10-17 01:31AM  DBV Technologies Announces Completion of Enrollment of the REALISE Study in Peanut Allergic Children GlobeNewswire
Mar-07-17 01:04PM  POWERSHARES DB G10 CURRENCY HARVEST FUND Financials
Mar-05-17 03:47PM  DBV Technologies :Data at AAAAI 2017 Show Lasting Response and Favorable Safety Profile of Investigational Agent, Viaskin Peanut, Throughout Three Years of Treatment of Peanut Allergic Children GlobeNewswire
Mar-01-17 06:22AM  POWERSHARES DB G10 CURRENCY HARVEST FUND Files SEC form 10-K, Annual Report
01:31AM  DBV Technologies to Attend Upcoming Investor Conferences GlobeNewswire
Feb-20-17 01:31AM  DBV Technologies Reports December 31, 2016 Cash Position GlobeNewswire
Feb-10-17 04:31PM  DBV to Present Data at the 2017 AAAAI Meeting Highlighting the Therapeutic Potential of EPIT® GlobeNewswire
Feb-03-17 01:31AM  DBV Technologies Announces Completion of Enrollment of Phase IIA Study of Viaskin Milk for the Treatment of Pediatric Eosinophilic Esophagitis GlobeNewswire
Jan-26-17 01:51AM  DBV Technologies to Present at the LEERINK Partners 6th Annual Global Healthcare Conference GlobeNewswire
Jan-10-17 10:46AM  The Top 3 Currency ETFs (UUP, DBV) Investopedia
Jan-09-17 01:40AM  DBV Technologies Announces Financial Calendar 2017 GlobeNewswire
Nov-28-16 02:26PM  POWERSHARES DB G10 CURRENCY HARVEST FUND Files SEC form 8-K, Entry into a Material Definitive Agreement, Financial St
Nov-08-16 03:53PM  POWERSHARES DB G10 CURRENCY HARVEST FUND Files SEC form 10-Q, Quarterly Report
Oct-25-16 05:12PM  POWERSHARES DB G10 CURRENCY HARVEST FUND Files SEC form 8-K, Termination of a Material Definitive Agreement
Aug-31-16 03:27PM  An ETF Capitalizing on Forex Market Carry Trade Opportunities ETF Trends
Aug-09-16 04:31PM  POWERSHARES DB G10 CURRENCY HARVEST FUND Files SEC form 10-Q, Quarterly Report
Aug-03-16 02:05AM  DBV Technologies SA :DBV-FR: Earnings Analysis: For the six months ended December 31, 2015 : August 3, 2016
Jun-22-16 12:00PM  Agriculture ETF (DBA) is Wednesday's 'Chart of the Day'
Jun-21-16 09:31AM  Calendar Could Be Good News For These Commodities ETFs
Jun-20-16 05:10PM  POWERSHARES DB G10 CURRENCY HARVEST FUND Files SEC form 8-K, Entry into a Material Definitive Agreement, Amendments t
Jun-10-16 09:30AM  Zacks Investment Ideas feature highlights: SPDR Gold Trust, iShares Gold Trust, PowerShares DB Gold Fund, UBS ETRACS CMCI Gold Total Return ETN and Rex Gold Hedged S&P 500 ETF
May-19-16 04:28AM  DBV Technologies SA :DBV-FR: Earnings Analysis: 2015 By the Numbers : May 19, 2016
May-10-16 04:00PM  POWERSHARES DB G10 CURRENCY HARVEST FUND Files SEC form 10-Q, Quarterly Report
Apr-22-16 03:00PM  POWERSHARES DB G10 CURRENCY HARVEST FUND Files SEC form 8-K, Termination of a Material Definitive Agreement
Mar-11-16 10:42AM  4 Inverse ETFs to Short Oil as Crude Prices Tumble
Feb-29-16 03:05PM  Inklings Of A Dollar ETF Rally
06:42AM  POWERSHARES DB G10 CURRENCY HARVEST FUND Files SEC form 10-K, Annual Report
Feb-22-16 06:05AM  POWERSHARES DB G10 CURRENCY HARVEST FUND Files SEC form 8-K, Entry into a Material Definitive Agreement, Financial St
Feb-10-16 07:51AM  ETF Ideas For The Japanese Government Bond Party
Dec-31-15 12:44PM  This Hedge Fund Manager's Worst Ideas For 2016 May Surprise You
Dec-30-15 11:13AM  8 Inverse Leveraged ETFs That Soared 70% or More in 2015
Dec-17-15 04:10PM  The Post-Fed Case For Dollar ETFs
Dec-07-15 09:30AM  The Zacks Analyst Blog Highlights: United States Oil Fund, PowerShares DB Oil Fund, PowerShares DB Crude Oil Short ETN, iShares Dow Jones Transportation Average Fund and iShares Dow Jones US Consumer Services Sector Index Fund
Dec-04-15 01:11PM  Profit From Sub-$40 Oil with These ETFs
Nov-23-15 09:10AM  The Long Dollar Trade Is Getting Really Crowded
Nov-18-15 02:18PM  It's All About The Benjamins, Baby: Dollar ETFs In Rarefied Air
Nov-06-15 03:34PM  POWERSHARES DB G10 CURRENCY HARVEST FUND Files SEC form 10-Q, Quarterly Report
10:51AM  Fresh Focus On Relief For Peanut Allergy Sufferers at Forbes
Oct-19-15 12:15PM  10 Leveraged/Inverse ETFs Winners YTD
Oct-08-15 10:15AM  Oil ETFs Head to Head: USO vs DBO
The investment seeks to track changes, whether positive or negative, in the level of the Deutsche Bank G10 Currency Future Harvest IndexaExcess Return. The index is comprised of long futures positions in the three eligible index currencies associated with the highest interest rates and short futures positions in the three eligible index currencies associated with the lowest interest rates. The indexas six component currencies from time-to-time, comprised of the three long and three short futures positions, are referred to as the index currencies and are used to calculate the value of the index.